Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

Abstract

Abstract Background Long term serum urate (SU) lowering to a target of Methods Patients with gout for Results Of the 273 patients enrolled into the study, 89 (32.6%) had SU concentration Conclusions ULT prescription and dosing are key modifiable factors associated with achieving SU target. These data support interventions focusing on improved use of ULT to optimise outcomes in patients with gout.

Keywords

• Gout
• Urate
• Target
• Allopurinol